Screener
BioCryst Pharmaceuticals BCRX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's prepaid & other current?
- BioCryst Pharmaceuticals (BCRX) reported prepaid & other current of $14.82M in Q2 2026.
- How has BioCryst Pharmaceuticals's prepaid & other current changed year-over-year?
- BioCryst Pharmaceuticals's prepaid & other current increased by 18.2% year-over-year, from $12.54M to $14.82M.
- What is the long-term trend for BioCryst Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's prepaid & other current has grown at a 25.5% compound annual growth rate (CAGR), from $5.53M to $17.18M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about BioCryst Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude